Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Robert Nishikawa

Concepts (209)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mammography
74
2018
460
10.530
Why?
Breast Neoplasms
61
2018
2690
4.290
Why?
Radiographic Image Interpretation, Computer-Assisted
36
2017
460
4.020
Why?
Calcinosis
38
2018
235
3.930
Why?
Diagnosis, Computer-Assisted
29
2017
322
3.460
Why?
Radiographic Image Enhancement
38
2018
465
3.110
Why?
Breast Diseases
22
2017
97
2.780
Why?
Pattern Recognition, Automated
12
2014
223
2.400
Why?
Algorithms
32
2018
1802
2.230
Why?
Breast
7
2018
262
1.570
Why?
Image Interpretation, Computer-Assisted
8
2015
668
1.520
Why?
Sensitivity and Specificity
37
2018
2054
1.430
Why?
ROC Curve
20
2014
731
1.400
Why?
Reproducibility of Results
31
2017
2588
1.230
Why?
Mass Screening
7
2018
601
1.200
Why?
Image Processing, Computer-Assisted
13
2018
1144
1.120
Why?
Artificial Intelligence
10
2014
177
0.990
Why?
X-Ray Film
4
2012
37
0.970
Why?
Models, Statistical
5
2013
572
0.930
Why?
Imaging, Three-Dimensional
8
2015
566
0.870
Why?
Models, Biological
5
2013
1759
0.820
Why?
Precancerous Conditions
6
2006
205
0.770
Why?
Female
70
2018
42943
0.650
Why?
Information Storage and Retrieval
5
2012
120
0.640
Why?
Humans
95
2018
79139
0.610
Why?
Technology Assessment, Biomedical
1
2013
31
0.540
Why?
Chemokine CXCL1
1
2012
9
0.500
Why?
Preventive Health Services
1
2011
50
0.470
Why?
X-Ray Intensifying Screens
6
2012
32
0.470
Why?
Early Detection of Cancer
1
2014
282
0.450
Why?
Diagnostic Errors
1
2012
166
0.450
Why?
Observer Variation
9
2013
616
0.440
Why?
Diagnostic Imaging
2
2015
434
0.430
Why?
Computer Simulation
6
2015
1019
0.420
Why?
Data Display
1
2009
22
0.410
Why?
Uterine Cervical Neoplasms
1
2012
236
0.410
Why?
Image Enhancement
5
2016
584
0.400
Why?
Carcinoma
1
2012
432
0.380
Why?
Biophysics
7
2002
151
0.350
Why?
Task Performance and Analysis
1
2006
85
0.330
Why?
Ovarian Neoplasms
1
2012
633
0.320
Why?
Tomography, X-Ray Computed
7
2017
2499
0.320
Why?
Artifacts
3
2006
234
0.310
Why?
Pattern Recognition, Visual
1
2006
153
0.300
Why?
Phantoms, Imaging
4
2013
390
0.240
Why?
False Positive Reactions
10
2002
224
0.240
Why?
Research Design
2
2017
549
0.220
Why?
Cluster Analysis
5
2010
360
0.220
Why?
Case-Control Studies
3
2016
1763
0.210
Why?
Contrast Media
2
2016
1043
0.200
Why?
Software
3
2013
628
0.190
Why?
Radiology
4
2014
169
0.190
Why?
Automation
2
2018
110
0.190
Why?
Models, Theoretical
5
2010
475
0.180
Why?
Government Regulation
1
2017
51
0.180
Why?
Likelihood Functions
3
2010
255
0.180
Why?
Fourier Analysis
3
2011
132
0.170
Why?
Conflict of Interest
1
2017
61
0.170
Why?
Radiography, Thoracic
6
2002
320
0.170
Why?
Equipment Failure Analysis
2
2009
98
0.170
Why?
Area Under Curve
3
2016
338
0.170
Why?
Subtraction Technique
3
2005
138
0.150
Why?
X-Rays
3
2013
126
0.150
Why?
Databases, Factual
9
2018
784
0.150
Why?
Registries
1
2018
598
0.150
Why?
Iodine
1
2012
35
0.130
Why?
Symporters
1
2012
75
0.130
Why?
Ovarian Cysts
1
2012
19
0.120
Why?
Carcinoma, Endometrioid
1
2012
34
0.120
Why?
Referral and Consultation
1
2014
309
0.120
Why?
Adenocarcinoma, Mucinous
1
2012
48
0.120
Why?
Biopsy
3
2013
1133
0.120
Why?
Nipples
1
2011
37
0.120
Why?
United States
4
2018
5963
0.120
Why?
Adenocarcinoma, Clear Cell
1
2012
58
0.120
Why?
Quality Improvement
1
2015
334
0.120
Why?
Diagnosis, Differential
3
2013
1570
0.120
Why?
Signal Processing, Computer-Assisted
2
2010
206
0.120
Why?
Statistics, Nonparametric
1
2012
323
0.120
Why?
Enzyme-Linked Immunosorbent Assay
1
2012
401
0.110
Why?
Hemangioma
1
2010
64
0.110
Why?
Photons
1
2010
36
0.110
Why?
Tomography, X-Ray
1
2009
18
0.110
Why?
Radionuclide Imaging
2
2006
233
0.100
Why?
Clinical Competence
1
2014
671
0.100
Why?
Computer Systems
3
2000
81
0.100
Why?
Muscle, Skeletal
1
2011
434
0.090
Why?
Logistic Models
1
2012
1126
0.090
Why?
Medical Oncology
1
2011
305
0.090
Why?
Equipment Design
1
2009
414
0.090
Why?
Neuropilin-1
1
2007
13
0.090
Why?
Cone-Beam Computed Tomography
1
2008
56
0.090
Why?
Hepatocyte Growth Factor
1
2007
85
0.090
Why?
Discrimination Learning
1
2006
58
0.080
Why?
Data Interpretation, Statistical
1
2007
300
0.080
Why?
Liver Neoplasms
1
2010
613
0.080
Why?
Glioma
1
2007
305
0.070
Why?
Evaluation Studies as Topic
5
1998
307
0.070
Why?
Solitary Pulmonary Nodule
2
2002
137
0.070
Why?
Magnetic Resonance Imaging
1
2016
3134
0.070
Why?
Absorptiometry, Photon
1
2004
98
0.070
Why?
Middle Aged
7
2016
24777
0.070
Why?
Evidence-Based Medicine
1
2006
431
0.070
Why?
Mathematics
3
1995
190
0.070
Why?
Bone Density
1
2004
204
0.070
Why?
Quality Assurance, Health Care
1
2004
219
0.060
Why?
Fuzzy Logic
1
2000
16
0.060
Why?
Neoplasms
1
2015
2484
0.060
Why?
Clinical Trials as Topic
1
2006
1169
0.060
Why?
Biophysical Phenomena
5
1998
121
0.050
Why?
Angiography
3
1995
206
0.050
Why?
Prognosis
1
2006
3545
0.050
Why?
Scattering, Radiation
2
2013
114
0.050
Why?
Discriminant Analysis
1
2017
61
0.040
Why?
Pilot Projects
2
2012
795
0.040
Why?
Brain Neoplasms
2
1996
786
0.040
Why?
United States Food and Drug Administration
1
2017
115
0.040
Why?
Analysis of Variance
2
2014
953
0.040
Why?
Population Surveillance
1
2018
236
0.040
Why?
Eye
1
1997
115
0.040
Why?
Adenomatous Polyposis Coli
1
1996
43
0.040
Why?
Adult
6
2016
25145
0.040
Why?
Signal Transduction
1
2007
3229
0.040
Why?
Neoplasms, Multiple Primary
1
1996
109
0.040
Why?
Copying Processes
1
1994
6
0.040
Why?
Diffusion of Innovation
1
2015
71
0.040
Why?
Attitude of Health Personnel
1
2000
637
0.040
Why?
Radiography
1
1996
861
0.040
Why?
Glioblastoma
1
1996
239
0.030
Why?
Expert Systems
1
1993
18
0.030
Why?
Forecasting
1
1995
311
0.030
Why?
Risk Factors
2
2016
5405
0.030
Why?
Retrospective Studies
3
2016
7317
0.030
Why?
Georgia
1
2012
21
0.030
Why?
Lung Neoplasms
2
2002
2013
0.030
Why?
Lasers
1
1992
96
0.030
Why?
Technology, Radiologic
2
1998
101
0.030
Why?
Adipose Tissue
1
2013
245
0.030
Why?
Quantum Theory
1
1989
26
0.030
Why?
Optics and Photonics
1
1989
27
0.030
Why?
Health Physics
1
1989
17
0.030
Why?
Luminescent Measurements
1
1989
62
0.030
Why?
Radiation Dosage
2
1994
219
0.030
Why?
Prevalence
1
2012
1191
0.020
Why?
Aged
4
2012
17854
0.020
Why?
Butadienes
1
2007
33
0.020
Why?
Carcinoma, Ductal
1
2007
17
0.020
Why?
Nitriles
1
2007
87
0.020
Why?
Carcinoma, Renal Cell
1
1990
364
0.020
Why?
Extracellular Signal-Regulated MAP Kinases
1
2007
119
0.020
Why?
Immunoblotting
1
2007
280
0.020
Why?
Radiology Information Systems
2
1999
78
0.020
Why?
Models, Structural
1
1986
59
0.020
Why?
Transplantation, Heterologous
1
2007
359
0.020
Why?
Tumor Burden
1
2007
276
0.020
Why?
Kidney Neoplasms
1
1990
550
0.020
Why?
Carcinoma, Ductal, Breast
1
2007
156
0.020
Why?
Neoplasms, Experimental
1
2007
283
0.020
Why?
Numerical Analysis, Computer-Assisted
1
2004
31
0.020
Why?
Proto-Oncogene Proteins c-met
1
2007
210
0.020
Why?
Transfection
1
2007
938
0.020
Why?
RNA, Small Interfering
1
2007
569
0.020
Why?
Neovascularization, Pathologic
1
2007
349
0.020
Why?
Computer Graphics
1
2004
98
0.020
Why?
Database Management Systems
1
2004
45
0.020
Why?
Aged, 80 and over
2
2012
6390
0.020
Why?
Radiometry
1
2004
45
0.020
Why?
Prospective Studies
1
2012
3924
0.020
Why?
Phosphorylation
1
2007
1141
0.020
Why?
Enzyme Inhibitors
1
2007
668
0.020
Why?
Decision Support Systems, Clinical
1
2004
108
0.020
Why?
User-Computer Interface
1
2004
183
0.020
Why?
Methylmethacrylate
2
1996
6
0.020
Why?
Methylmethacrylates
2
1996
10
0.020
Why?
Disease Progression
1
2007
1411
0.020
Why?
Follow-Up Studies
2
2001
3733
0.020
Why?
Cell Line
1
2007
2580
0.010
Why?
Gene Expression Regulation, Neoplastic
1
2007
1165
0.010
Why?
Cell Line, Tumor
1
2007
2348
0.010
Why?
Cell Proliferation
1
2007
1561
0.010
Why?
Fibrocystic Breast Disease
1
1999
13
0.010
Why?
Fibroadenoma
1
1999
11
0.010
Why?
False Negative Reactions
1
1998
71
0.010
Why?
Severity of Illness Index
1
2005
1847
0.010
Why?
Male
4
2010
40432
0.010
Why?
Lead
1
1996
22
0.010
Why?
Colloids
1
1996
32
0.010
Why?
Age Distribution
1
1996
205
0.010
Why?
Printing
1
1994
4
0.010
Why?
Densitometry
1
1994
29
0.010
Why?
Carcinoma, Transitional Cell
1
1996
141
0.010
Why?
Chi-Square Distribution
1
1995
384
0.010
Why?
Bone and Bones
1
1995
263
0.010
Why?
Mice
1
2007
10748
0.010
Why?
Urinary Bladder Neoplasms
1
1996
315
0.010
Why?
Pulmonary Fibrosis
1
1993
117
0.010
Why?
Comorbidity
1
1996
874
0.010
Why?
Stomach Neoplasms
1
1996
295
0.010
Why?
Coronary Angiography
1
1993
219
0.010
Why?
Lung Diseases
1
1993
261
0.010
Why?
Time Factors
1
1999
5382
0.010
Why?
Adenocarcinoma
1
1996
1224
0.010
Why?
Animals
1
2007
26163
0.010
Why?
Epoxy Resins
1
1986
1
0.010
Why?
Combined Modality Therapy
1
1990
1644
0.010
Why?
Computers
1
1986
105
0.010
Why?
Quality Control
1
1986
123
0.010
Why?
Survival Rate
1
1990
1899
0.010
Why?
Brain
1
1990
2075
0.000
Why?
Nishikawa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Physical Neighbors Expand Description
_